September 14, 2025

Aiming to Refine NSCLC Targeted Therapy

The first study to prospectively examine the impact of co-mutation biomarkers on sotorasib, a novel targeted therapy, for advanced KRAS G12C mutated NSCLC

Fox Chase Cancer Center

September 10, 2025

Update to ASCO Living Guideline for NSCLC Without Driver Alterations Includes First Comparison of Immunotherapy Options

ASCO has issued a new update to its living guideline regarding therapy for stage IV non–small cell lung cancer (NSCLC) without driver alterations, based on results of three studies published recently....

The ASCO Post

September 03, 2025

Temple Lung Center Performs First U.S. BREATHE-3 Procedure for Severe Emphysema

The Phase-3 trial of Apreo Health’s bronchoscopic airway scaffold for severe emphysema and hyperinflation is now enrolling at the Temple Lung Center.

Temple Health

September 03, 2025

Inhaler Cataract Risk

Childhood asthma and inhaled corticosteroids linked to increased cataract risk in adulthood, says Danish study

The Ophthalmologist

August 22, 2025

Personalizing First-Line Therapy in NSCLC: Plasma-Guided Adaptive Treatment Approach

In patients with newly diagnosed, PD-L1–positive, advanced non–small cell lung cancer (NSCLC) who tested negative for driver mutations, implementation of plasma-guided treatment intensification—from m...

The ASCO Post

August 22, 2025

Updated CHEST Guidelines Emphasize Minimally Invasive Surgery for Early-Stage NSCLC

Updated clinical guidelines for the management of patients with early-stage non–small cell lung cancer (NSCLC) from the American College of Chest Physicians (CHEST) recommend use of more minimally inv...

The ASCO Post

August 20, 2025

New Strategy for Small Cell Lung Cancer Treatment Emerges from Dana-Farber Science

Dana-Farber researchers have provided the mechanistic and preclinical evidence needed to support a clinical trial of a new class of drugs called direct cyclin inhibitors in patients with a range of cancers.

Dana-Farber

July 24, 2025

Study Paves Path to Improved Diagnosis, Treatment of NUT Carcinoma

Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests required for an accurate diagnosis.

Dana-Farber

August 19, 2025

AAP Vaccine Recommendations Veer From ACIP

AAP released 2025 evidence-based US childhood and adolescent immunization schedule with updates for RSV, influenza, COVID-19, HPV, and meningococcal vaccines.

Conexiant